From: An update of the long-term outcome of patients with nonspecific pleurisy at medical thoracoscopy
Variables | Values |
---|---|
Age, years, mean ± SD | 61.8 ± 14.5 |
Sex, male/female, n (%) | 98/56 (63.6/36.4) |
Smoking status, n (%) | |
Non-smoker | 81 (52.6) |
Current or previous smoker | 73 (47.4) |
Follow up duration (months) | 61.5 ± 43.7 |
Diagnosis of pleural malignancy during follow-up | |
Lung cancer | 7 (36.8) |
Mesothelioma | 6 (31.6) |
Gynaecological tumor | 2 (10.5) |
Breast tumor | 1 (5.3) |
Prostatic cancer | 1 (5.3) |
Plasmacytoma | 1 (5.3) |
Thymoma | 1 (5.3) |
Diagnosis of pleural benign disease during follow-up | |
Tuberculosis-induced | 24 (35.3) |
Heart failure | 16 (23.5) |
Parapneumonic effusion | 13 (19.1) |
Connective tissue diseases | 5 (7.4) |
Pulmonary embolism | 4 (5.9) |
Pneumosilicosis | 4 (5.9) |
After splenic embolization surgery | 1 (1.5) |
After coronary artery bypass grafting | 1 (1.5) |